SATIVEX Trademark

Trademark Overview

On Wednesday, June 23, 2021, a trademark application was filed for SATIVEX with the United States Patent and Trademark Office. The USPTO has given the SATIVEX trademark a serial number of 79318507. The federal status of this trademark filing is REGISTERED as of Tuesday, June 27, 2023. This trademark is owned by GW Pharma Ltd. The SATIVEX trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, providing online and in-person classes, seminars, training workshops, training classes, and presentations in the field of medicine, education, cannabis, pharmaceuticals, and healthcare; provision of training in the field of medical cannabidiol; pharmaceuticals instruction services, namely, providing courses of in the field of medical cannabidiol; educational services, namely, organising and conducting conferences, seminars, educational exhibitions and workshops in the field of medical cannabidiol; provision of on-line electronic publications in the nature of newsletters and factsheets in the field of medical cannabidiol; publication of texts, other than publicity texts; publication of scientific texts, other than publicity texts
sativex

General Information

Serial Number79318507
Word MarkSATIVEX
Filing DateWednesday, June 23, 2021
Status700 - REGISTERED
Status DateTuesday, June 27, 2023
Registration Number7088758
Registration DateTuesday, June 27, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements

Goods and ServicesEducational services, namely, providing online and in-person classes, seminars, training workshops, training classes, and presentations in the field of medicine, education, cannabis, pharmaceuticals, and healthcare; provision of training in the field of medical cannabidiol; pharmaceuticals instruction services, namely, providing courses of in the field of medical cannabidiol; educational services, namely, organising and conducting conferences, seminars, educational exhibitions and workshops in the field of medical cannabidiol; provision of on-line electronic publications in the nature of newsletters and factsheets in the field of medical cannabidiol; publication of texts, other than publicity texts; publication of scientific texts, other than publicity texts

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, March 7, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJazz Pharmaceuticals Research UK Limited
Party Type32 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressGB
Party NameGW Research Limited
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressGB
Party NameGW Pharma Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameGW Pharma Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameGW Pharma Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, August 19, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, August 26, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, August 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 31, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, November 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Sunday, March 20, 2022ASSIGNED TO EXAMINER
Friday, May 27, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, June 7, 2022ASSIGNED TO EXAMINER
Friday, June 17, 2022NON-FINAL ACTION WRITTEN
Saturday, June 18, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 23, 2022REFUSAL PROCESSED BY MPU
Thursday, June 23, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 12, 2022REFUSAL PROCESSED BY IB
Thursday, December 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, February 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, March 6, 2023ASSIGNED TO LIE
Monday, March 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 19, 2023NOTIFICATION PROCESSED BY IB
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, September 25, 2023CHANGE OF OWNER RECEIVED FROM IB
Wednesday, September 27, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 27, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 16, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 11, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

sativex field cannabidiol texts medical educational namely training services pharmaceuticals seminars